Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations.

Yaping ChangMeng ZhuChristopher VannabouathongRaman MundiRoland S ChouMohit Bhandari

Published in: Pain research & management (2021)

Clinicians can attend to the guidance currently offered, being aware that only weak recommendations are available for medical cannabis in patients with CNCP, as a third- or fourth-line therapy. Detailed discussions with patients regarding the benefits in reducing pain and potential adverse effects are required before its prescription.

Keyphrases

healthcare
chronic pain
end stage renal disease
pain management
ejection fraction
neuropathic pain
newly diagnosed
clinical practice
peritoneal dialysis
prognostic factors
palliative care
stem cells
spinal cord
risk assessment
cell therapy
bone marrow
human health
drug induced
health information